Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.21
-0.12 (-0.97%)
At close: Aug 19, 2025, 11:59 AM

Dyne Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-317.42M -235.94M -168.1M -149.29M
Depreciation & Amortization
-1.93M 571K 1.68M 1.09M
Stock-Based Compensation
45.86M 19.97M 15.18M 17.54M
Other Working Capital
-10.54M 3.34M -4.14M -4.45M
Other Non-Cash Items
n/a 929K 2.97M -746K
Deferred Income Tax
n/a n/a n/a 2.59M
Change in Working Capital
-19.49M 26.31M -5.38M 9.26M
Operating Cash Flow
-292.37M -188.16M -153.65M -119.56M
Capital Expenditures
-2.38M -729K -3.07M -3.62M
Cash Acquisitions
n/a n/a 34K 8K
Purchase of Investments
-317.44M -44.26M -121.18M -236.72M
Sales Maturities Of Investments
115.71M 128.3M 211.44M 102.45M
Other Investing Acitivies
35K n/a -34K -8K
Investing Cash Flow
-204.08M 83.31M 87.2M -137.89M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
36.84M 1.95M 529K 584K
Financial Cash Flow
809.89M 54.32M 37.39M 157.82M
Net Cash Flow
313.45M -50.52M -29.05M -99.63M
Free Cash Flow
-294.75M -188.89M -156.71M -123.18M